The Emergency Committee of the World Health Organization (WHO) said today that it is possible to anticipate that the pandemic of coronavirus will last a long time and that is why we must maintain the efforts made to contain it in communities, regions, countries and the entire world.
The group of scientists met virtually to assess the evolution of the pandemic of coronavirus from the review and discussion of all the scientific information on the SARS CoV-2 coronavirus that has emerged in the three months since their last meeting.
The committee is made up of eighteen scientists from different countries and corresponds to the WHO Director-General, Tedros Adhanom Ghebreyesus, summon him and receive his recommendations. As expected, the group of experts in different medical and scientific disciplines agreed that the outbreak of COVID-19 it continues to be an international health emergency.
“The pandemic is a health crisis that occurs only once a century and its effects will be felt in the coming decades,” he said. Tedros to the Committee according to a statement from the who.
“Many countries that believed that the worst was over are now facing new outbreaks; some who were less affected in the first weeks are now seeing the increase in cases and deaths, while others who had large outbreaks have managed to control them, “he summarized. Tedros.
Among the main recommendations that were made to the who They include continuing to support countries with lesser capacities to maintain their medical services and to continue promoting research aimed at finding one or more treatments and vaccines for COVID-19.
The objective is that when the time is right, the countries with the lowest resources are not left out of the distribution of vaccines or medicines due to their inability to pay for them. In short, its distribution is as equitable as possible.
Actually three potential vaccines (of American, British and Chinese origin) are in phase 3 of clinical trials, which will determine if they work or not and if they are safe. The who In this regard, he has indicated that he estimates that a vaccine will be ready for commercialization “in the first part of 2021”, at the earliest.